1. A pathway-dependent on apoE, ApoAI, and ABCA1 determines formation of buoyant high-density lipoprotein by macrophage foam cells. Yancey PG, Yu H, Linton MF, Fazio S (2007) Arterioscler Thromb Vasc Biol 27(5): 1123-31
    › Primary publication · 17303773 (PubMed)
  2. Angiotensin inhibition decreases progression of advanced atherosclerosis and stabilizes established atherosclerotic plaques. Suganuma E, Babaev VR, Motojima M, Zuo Y, Ayabe N, Fogo AB, Ichikawa I, Linton MF, Fazio S, Kon V (2007) J Am Soc Nephrol 18(8): 2311-9
    › Primary publication · 17634441 (PubMed)
  3. A new age of discovery for plasma lipoproteins. Fazio S, Linton MF (2007) Curr Opin Lipidol 18(4): 387-8
    › Primary publication · 17620853 (PubMed)
  4. Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice. Ayabe N, Babaev VR, Tang Y, Tanizawa T, Fogo AB, Linton MF, Ichikawa I, Fazio S, Kon V (2006) Atherosclerosis 184(2): 312-21
    › Primary publication · 16023123 (PubMed)
  5. Sorting out the complexities of reverse cholesterol transport: CETP polymorphisms, HDL, and coronary disease. Fazio S, Linton MF (2006) J Clin Endocrinol Metab 91(9): 3273-5
    › Primary publication · 16960121 (PubMed)
  6. Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis. Baumgartl J, Baudler S, Scherner M, Babaev V, Makowski L, Suttles J, McDuffie M, Tobe K, Kadowaki T, Fazio S, Kahn CR, Hotamisligil GS, Krone W, Linton M, BrĂ¼ning JC (2006) Cell Metab 3(4): 247-56
    › Primary publication · 16581002 (PubMed) · PMC4027059 (PubMed Central)
  7. Macrophage apolipoprotein E reduces atherosclerosis and prevents premature death in apolipoprotein E and scavenger receptor-class BI double-knockout mice. Yu H, Zhang W, Yancey PG, Koury MJ, Zhang Y, Fazio S, Linton MF (2006) Arterioscler Thromb Vasc Biol 26(1): 150-6
    › Primary publication · 16269665 (PubMed)
  8. Intracellular trafficking of recycling apolipoprotein E in Chinese hamster ovary cells. Braun NA, Mohler PJ, Weisgraber KH, Hasty AH, Linton MF, Yancey PG, Su YR, Fazio S, Swift LL (2006) J Lipid Res 47(6): 1176-86
    › Primary publication · 16534141 (PubMed)
  9. Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus. Stanic AK, Stein CM, Morgan AC, Fazio S, Linton MF, Wakeland EK, Olsen NJ, Major AS (2006) Proc Natl Acad Sci U S A 103(18): 7018-23
    › Primary publication · 16636270 (PubMed) · PMC1459011 (PubMed Central)
  10. Failure of ACAT inhibition to retard atherosclerosis. Fazio S, Linton M (2006) N Engl J Med 354(12): 1307-9
    › Primary publication · 16554534 (PubMed)